Search results for "Dizziness"
New drugs approved for type 2 diabetes and COPD
This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.
https://immattersacp.org/archives/2014/03/fda.htm
1 Mar 2014
Cardiac risks of testosterone, saxagliptin under investigation
This regulatory update covers an FDA review of the risk of stroke, heart attack and death in men taking testosterone products, as well as a possible increase in heart failure associated with saxagliptin.
https://immattersacp.org/archives/2014/04/fda.htm
1 Apr 2014
For hypertension, how low to go?
Updated blood pressure guidelines may have created more questions than closure, internists have found, as they try to determine how aggressively to treat the condition and what goals to set for subpopulations of patients, such as those with diabetes. Experts react to the “paradigm shift” in lowering hypertension.
https://immattersacp.org/archives/2014/04/hypertension.htm
1 Apr 2014
Maintaining men's health in middle age
Adrenopause, somatopause, andropause... manopause? They all give internists pause when considering men's health as they reach middle age. As men try to maintain optimum health, doctors need to define what exactly that is.
https://immattersacp.org/archives/2014/04/mens-health.htm
1 Apr 2014
Medical marijuana may help relieve some multiple sclerosis symptoms but has several safety concerns
Certain forms of medical marijuana can help treat some symptoms of multiple sclerosis (MS), but they do not appear to be helpful in treating drug-induced movements in Parkinson's disease, a review by the American Academy of Neurology found.
https://immattersacp.org/weekly/archives/2014/04/29/1.htm
29 Apr 2014
Doripenem not for pneumonia; migraine device approved
This update covers a labeling change for doripenem (Doribax) and a warning about risk of death for ventilator patients with pneumonia, among other regulatory actions.
https://immattersacp.org/archives/2014/05/fda.htm
1 May 2014
New grass allergy treatment, opioid overdose solution
This update covers approval of an allergen extract to treat allergic rhinitis induced by grass pollen and of a handheld injector of naloxone for emergency treatment of known or suspected opioid overdose.
https://immattersacp.org/archives/2014/06/fda.htm
1 Jun 2014
MKSAP Quiz: evaluation for health insurance
A 21-year-old man is evaluated during a medical examination for health insurance. The patient is a weight lifter. He has no medical problems and takes no medications or illicit drugs. Following a physical exam, electrocardiogram, and echocardiogram, what is the most likely diagnosis?
https://immattersacp.org/weekly/archives/2014/08/05/3.htm
5 Aug 2014
New warning for testosterone, approval for inhaled insulin
This update covers a revised warning on testosterone products about the risk of venous thromboembolism, and approval of a fast-acting inhaled insulin to treat diabetes in adults.
https://immattersacp.org/archives/2014/09/fda.htm
1 Sep 2014
New diabetes drug, LABA for COPD, skin antibiotic approved
This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a new intravenous drug for bacterial skin and skin-structure infections.
https://immattersacp.org/archives/2014/10/fda.htm
1 Oct 2014